Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A
- L. Barile, E. Cervio, +14 authors G. Vassalli
- Medicine, Chemistry
- Cardiovascular research
- 1 June 2018
Aims
Cell therapy trials using cardiac-resident progenitor cells (CPCs) and bone marrow-derived mesenchymal stem/progenitor cells (BMCs) in patients after myocardial infarction have provided… Expand
Hypoxia/Reoxygenation Cardiac Injury and Regeneration in Zebrafish Adult Heart
- V. Parente, S. Balasso, +8 authors M. Capogrossi
- Biology, Medicine
- PloS one
- 16 January 2013
Aims the adult zebrafish heart regenerates spontaneously after injury and has been used to study the mechanisms of cardiac repair. However, no zebrafish model is available that mimics ischemic injury… Expand
Myocardial tolerance to ischemia–reperfusion injury, training intensity and cessation
- F. Esposito, Raffaella Ronchi, +5 authors M. Samaja
- Medicine
- European Journal of Applied Physiology
- 1 May 2011
Training has been shown to induce cardioprotection. The mechanisms involved remain still poorly understood. Aims of the study were to examine the relevance of training intensity on myocardial… Expand
Chronic hypoxia: a model for cyanotic congenital heart defects.
- A. Corno, G. Milano, M. Samaja, P. Tozzi, L. V. von Segesser
- Medicine
- The Journal of thoracic and cardiovascular…
- 1 July 2002
OBJECTIVE
The postoperative course of cyanotic children is generally more complicated than that of acyanotic children. A possible reason is reoxygenation injury at the beginning of cardiopulmonary… Expand
A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo.
- G. Milano, S. Morel, +4 authors G. Vassalli
- Medicine
- American journal of physiology. Heart and…
- 1 April 2007
The c-Jun NH(2)-terminal kinase (JNK) pathway of the mitogen-activated protein kinase (MAPK) signaling cascade regulates cell function and survival after stress stimulation. Equally robust studies… Expand
Daily reoxygenation decreases myocardial injury and improves post-ischaemic recovery after chronic hypoxia.
- G. Milano, A. Corno, M. Samaja, S. Morel, G. Vassalli, L. V. von Segesser
- Medicine
- European journal of cardio-thoracic surgery…
- 1 April 2010
OBJECTIVE
In contrast to the clinical evidence, experimental studies showed that chronic hypoxia (CH) confers a certain degree of protection against ischaemia-reperfusion damage. We studied the… Expand
Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation
- G. Vassalli, G. Milano, T. Moccetti
- Medicine
- Journal of transplantation
- 18 March 2012
In solid organ transplantation, ischemia/reperfusion (IR) injury during organ procurement, storage and reperfusion is an unavoidable detrimental event for the graft, as it amplifies graft… Expand
Hypoxia: unique myocardial morphology?
- A. Corno, G. Milano, +4 authors L. V. von Segesser
- Medicine
- The Journal of thoracic and cardiovascular…
- 1 May 2004
OBJECTIVE
The objective of this study was to investigate the effects of chronic and intermittent hypoxia on myocardial morphology.
METHODS
Rats randomly divided into 3 groups (n = 14 per group)… Expand
Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse.
- R. Parapanov, J. Lugrin, +7 authors L. Liaudet
- Biology, Medicine
- Clinical science
- 1 July 2015
Myocardial ischaemia-reperfusion (MIR) triggers a sterile inflammatory response important for myocardial healing, but which may also contribute to adverse ventricular remodelling. Such inflammation… Expand
Intravenous administration of cardiac progenitor cell-derived exosomes protects against doxorubicin/trastuzumab-induced cardiac toxicity.
- G. Milano, V. Biemmi, +8 authors G. Vassalli
- Chemistry, Medicine
- Cardiovascular research
- 30 April 2019
BACKGROUND
Combined administration of anthracyclines (e.g., doxorubicin; Dox) and trastuzumab (Trz), a humanized anti-human epidermal growth factor receptor 2 (HER2; ErbB2), is an effective treatment… Expand